|
|
|
| Metabolic syndrome and malignant neoplasms |
| 1AN Yun-feng , 1LI Xia, 2XIANG Yue-ying, 1ZHANG He-jun, 1XIANG Zhen |
| 1Department of Health Management, No.181 Hospital of PLA, Guilin 541002, Guangxi, China; 2School of Health Management, Guangxi Normal University, Guilin 541004, Guangxi, China |
|
|
|
|
Abstract Malignant tumor has been a major diseases threat to human health, with current social habits, diet, living environment and other factors changing, the incidence of malignant tumors have also undergone significant changes. The set of diabetes/ hyperglycemia, hyperlipidemia and hypertension, which is obesity, has been a risk factor for many kinds of major diseases. A growing number of studies confirmed that a variety of malignant tumor associated with MetS, MetS and malignant tumor have been a global problem threatened human health. In recent years, the further researche of basic medical sciences and epidemiology on MetS-induced malignant tumor clarified the intimate relationship between MetS and malignancy, each factor of MetS is interrelated, the accumulation of individual factors increased the risk of cancer and mortality. With further research, the molecular mechanisms are gradually discovered, the molecular mechanism which accumulation of risk factors induced tumor is more explicit, possible mechanisms include: the role of long-term hyperglycemia, obesity and hyperlipidemia, the role of insulin factor and secretion factor interferences which coordinate the action, and the prevention and treatment in clinical of tumor is also gradually improved. This review will describe the association between metabolic syndrome and malignant tumor from the points of the epidemiology and molecular mechanism based on recent years related research.
|
|
|
|
|
|
| [1] |
SHI Han-ping， LIANG Xiao-xiao. Analysis of nutritional status of hospitalized patients with type 2 diabetes mellitus[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 342-345. |
| [2] |
WANG Chao-yun， DU Cheng， GUAN Xin， DU Xiao-wei， XU Zhu-xuan， ZHENG Zhen-dong. Advances in drug therapy for cancer cachexia[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 382-385. |
| [3] |
SHENG Xiang， LI Su-yi. Advances in research on intestinal microecology and clinical outcomes of tumors[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 178-182. |
| [4] |
CHONG Xiao-yi， ZHANG Xiao-tian. Impact of obesity on therapy response and clinical outcomes in cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 172-177. |
| [5] |
1, 3YUAN Fei, 2, 3, 4WANG Shu-bin. Progress of ribosomal protein in malignant tumor therapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(1): 116-119. |
| [6] |
1FENG Juan, 1FAN Xiao-tang, 1HALIDA Xiaerfuhazi, 2REN Zhi-hui, 3Li Liang, 1HE Fang-ping . Correlation between serum leptin level and hepatocellular carcinoma (HCC) based on hepatitis B cirrhosis[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(1): 83-88. |
|
|
|
|
